Form 4: Inspire Medical Systems' Chief Technology Officer Sells Shares
SEC Filing
John Rondoni, Chief Technology Officer of Inspire Medical Systems, sold 31 shares of common stock at a price of $215 per share on September 9, 2024, according to a Form 4 filing.
Summary
- John Rondoni, the Chief Technology Officer of Inspire Medical Systems, Inc. (INSP), reported a transaction involving the sale of company stock.
- On September 9, 2024, Rondoni sold 31 shares of common stock at a price of $215 per share.
- Following the transaction, Rondoni directly owns 11,348 shares of Inspire Medical Systems.
- The sale was executed under a pre-arranged Rule 10b5-1 trading plan established on May 23, 2024.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing related to an insider stock sale. It doesn't inherently convey positive or negative sentiment about the company's performance or prospects.
Industry Context
This is a routine disclosure of an insider transaction. It's common for executives to sell shares periodically for personal financial management, often under pre-arranged trading plans to avoid accusations of trading on inside information.
Key Dates
| Date | Description |
|---|---|
| May 23, 2024 | Date of Rule 10b5-1 trading plan |
| September 9, 2024 | Date of stock sale transaction |
| September 11, 2024 | Date of Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.